X-ray imaging with Micromegas detectors with optical readout
Authors:
A. Cools,
S. Aune,
F. Beau,
F. M. Brunbauer,
T. Benoit,
D. Desforge,
E. Ferrer-Ribas,
A. Kallitsopoulou,
C. Malgorn,
E. Oliveri,
T. Papaevangelou,
E. C. Pollacco,
L. Ropelewski,
A. Sari,
F. J. Iguaz
Abstract:
In the last years, optical readout of Micromegas gaseous detectors has been achieved by implementing a Micromegas detector on a glass anode coupled to a CMOS camera. Effective X-ray radiography was demonstrated using integrated imaging approach. High granularity values have been reached for low-energy X-rays from radioactive sources and X-ray generators.
Detector characterization with X-ray radi…
▽ More
In the last years, optical readout of Micromegas gaseous detectors has been achieved by implementing a Micromegas detector on a glass anode coupled to a CMOS camera. Effective X-ray radiography was demonstrated using integrated imaging approach. High granularity values have been reached for low-energy X-rays from radioactive sources and X-ray generators.
Detector characterization with X-ray radiography has led to two applications: neutron imaging for non-destructive examination of highly gamma-ray emitting objects and beta imaging for the single cell activity tagging in the field of oncology drug studies.
First measurements investigating the achievable spatial resolution of the glass Micromegas detector at the SOLEIL synchrotron facility with a high-intensity and flat irradiation field will be shown in this article.
△ Less
Submitted 30 March, 2023;
originally announced March 2023.
Medica-Plus: a Micromegas-based proof-of-concept detector for sub-becquerel tritium activity assessment at the service of oncological research
Authors:
F. Jambon,
S. Aune,
P. Baron,
T. Benoit,
T. Bey,
D. Desforge,
E. Ferrer-Ribas,
A. Grabas,
M. Kebbiri,
I. Mandjavidze,
T. Papaevangelou,
M. Riallot,
M. Vandenbroucke,
F. Beau,
V. Dive,
C. Malgorn,
F. Malloggi,
A. Rousselot,
F. Carrel,
M. Trocmé
Abstract:
To fulfill needs in oncological research a new Micromegas detector has been developed to follow radiolabelled drugs in living organisms at the single cell level. This article describes the proof-of-concept of such a detector and compares its ability to detect and assess sub-becquerel \tritium~activities with a commercial $β$-imager
To fulfill needs in oncological research a new Micromegas detector has been developed to follow radiolabelled drugs in living organisms at the single cell level. This article describes the proof-of-concept of such a detector and compares its ability to detect and assess sub-becquerel \tritium~activities with a commercial $β$-imager
△ Less
Submitted 20 September, 2021;
originally announced September 2021.
